| All patients | Sex | Fracture | Started treatment | Previous use of bisphosphonate | Treatment prescribed | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Women | Men | Hip | Forearm | Rheumatology | Primary care | Yes | No | Oral biphosphonates | Denosumab | ||||
| Continued treatment | 71.3% | 76% | 45% | 69% | 68% | 74% | 69% | 86% | 68% | 71% | 88% | ||
| Stopped or not initiated treatment | 28.7% | 24% | 55% | 31% | 32% | 26% | 31% | 14% | 32% | 29% | 12% | ||
| P | <0.001 | 0.91 | 0.32 | 0.002 | 0.06 | ||||||||